威高骨科(688161.SH)：2025年中报净利润为1.42亿元

Financial Performance - The company reported a total revenue of 741 million yuan, a decrease of 9.62 million yuan compared to the same period last year, representing a year-on-year decline of 1.28% [1] - The net profit attributable to shareholders was 142 million yuan, with net cash inflow from operating activities amounting to 186 million yuan [1] Financial Ratios - The latest debt-to-asset ratio is 19.69%, ranking 50th among disclosed peers, with an increase of 0.63 percentage points from the previous quarter [3] - The latest gross profit margin stands at 66.50%, and the return on equity (ROE) is 3.52% [3] Earnings and Turnover - The diluted earnings per share are 0.35 yuan [4] - The total asset turnover ratio is 0.15 times, ranking 65th among disclosed peers, while the inventory turnover ratio is 0.38 times, ranking 93rd [4] Shareholder Structure - The number of shareholders is 9,034, with the top ten shareholders holding 354 million shares, accounting for 88.53% of the total share capital [4] - The largest shareholder is Shandong Weigao Group Medical Polymer Co., Ltd., holding 50.63% of the shares [4]